BRAVECTO® Plus launched in the UK

In 2016, MSD Animal Health launched BRAVECTO® spot-on, a topical solution for dogs and cats. Now the company has launched BRAVECTO® Plus in the UK, a combination (fluralaner plus moxidectin) topical solution for cats. Fluralaner is an ectoparasiticide which provides systemic activity against ticks and fleas, protecting the cat for 12 weeks. Moxidectin is an endectocide which provides systemic activity against a range of internal worms including intestinal roundworm and hookworm, and prevents heartworm disease for 8 weeks. In addition, the product can be used to treat flea allergy dermatitis.
MSD Animal Health’s marketing manager, Amanda Melvin, said: “These parasites are not just a nuisance, but also pose animal and human health risks, as ticks and fleas can transmit disease. We are pleased to introduce the latest innovation in feline parasite protection to the BRAVECTO® family.”